MedPath
TGA Approval

Cellular Therapies - T Cells - Brexucabtagene autoleucel, cryopreserved - T - Tecartus - Gilead Sciences Pty Ltd - Injection, intravenous infusion - Bag (396794)

396794

Cellular Therapies - T Cells - Brexucabtagene autoleucel, cryopreserved - T - Tecartus - Gilead Sciences Pty Ltd - Injection, intravenous infusion - Bag

Gilead Sciences Pty Ltd

September 30, 2022

Biological

Biological

Active

Included

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/22570549d81e00e89615c3834d4ee139.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/1b7af162538fc6f5d933989ca2f8e3b5.pdf

Active Ingredients

brexucabtagene autoleucel

© Copyright 2025. All Rights Reserved by MedPath